Literature DB >> 30674488

Anaphylaxis to patent blue dye in a 17-year-old boy.

Mélanie Leung1, Christine McCusker2, Moshe Ben-Shoshan3.   

Abstract

Patent blue V dye (PBV) is frequently used as a perioperative drug for lymphangiography, as well as a food additive. Hypersensitivity to PBV is poorly documented in adults and had not been previously described in children. The diagnosis of PBV allergy depends on corroboration of history consistent with an IgE-mediated reaction and confirmatory skin tests. We present in this paper a paediatric case of PBV anaphylaxis and of biphasic reaction that exemplifies the challenges involved in diagnosing and managing this rare but potentially life-threatening allergic reaction. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drug therapy related to surgery; immunology; medical management; paediatrics (drugs and medicines); unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2019        PMID: 30674488      PMCID: PMC6347920          DOI: 10.1136/bcr-2018-226191

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

1.  Dye-assisted lymphatic-sparing laparoscopic varicocelectomy in children.

Authors:  John-Paul Capolicchio; Mohamed El-Sherbiny; Alex Brzezinski; Waleed Eassa; Roman Jednak
Journal:  J Pediatr Urol       Date:  2011-12-01       Impact factor: 1.830

Review 2.  Anaphylaxis: past, present and future.

Authors:  M Ben-Shoshan; A E Clarke
Journal:  Allergy       Date:  2011-01       Impact factor: 13.146

3.  Anaphylaxis and other adverse reactions to blue dyes: a case series.

Authors:  J D Howard; V Moo; P Sivalingam
Journal:  Anaesth Intensive Care       Date:  2011-03       Impact factor: 1.669

4.  Biphasic and protracted anaphylaxis to iodinated contrast media.

Authors:  Tae-Hyung Kim; Soon Ho Yoon; Suh-Young Lee; Young Hun Choi; Chang Min Park; Hye-Ryun Kang; Sang-Heon Cho
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

Review 5.  Time of Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic Review and Meta-analysis.

Authors:  Sangil Lee; M Fernanda Bellolio; Erik P Hess; Patricia Erwin; Mohammad Hassan Murad; Ronna L Campbell
Journal:  J Allergy Clin Immunol Pract       Date:  2015-02-11

6.  Patent Blue V dye anaphylaxis: experience of Australian and New Zealand surgeons.

Authors:  April Wong; Andrew Spillane
Journal:  ANZ J Surg       Date:  2012-09-26       Impact factor: 1.872

7.  Biphasic anaphylactic reactions in pediatrics.

Authors:  J M Lee; D S Greenes
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

8.  Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.

Authors:  K Brockow; L H Garvey; W Aberer; M Atanaskovic-Markovic; A Barbaud; M B Bilo; A Bircher; M Blanca; B Bonadonna; P Campi; E Castro; J R Cernadas; A M Chiriac; P Demoly; M Grosber; J Gooi; C Lombardo; P M Mertes; H Mosbech; S Nasser; M Pagani; J Ring; A Romano; K Scherer; B Schnyder; S Testi; M Torres; A Trautmann; I Terreehorst
Journal:  Allergy       Date:  2013-04-25       Impact factor: 13.146

9.  Adverse drug reaction, patent blue V dye and anaesthesia.

Authors:  Swagata Tripathy; Priya V Nair
Journal:  Indian J Anaesth       Date:  2012-11

10.  Biphasic anaphylactic reaction to blue dye during sentinel lymph node biopsy.

Authors:  Margaret I Liang; William E Carson
Journal:  World J Surg Oncol       Date:  2008-07-27       Impact factor: 2.754

View more
  3 in total

Review 1.  Anaphylaxis to drug excipients.

Authors:  Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2022-05-31

Review 2. 

Authors:  Wolfgang Pfützner
Journal:  Allergo J       Date:  2022-07-25

3.  Case report: Atypical anaphylactic reaction to Patent Blue V dye during breast cancer surgery.

Authors:  Stanka Misir Šitum; Iva Korečić Zrinjščak; Maja Pečvarac; Andrea Šoštar; Ana Žaja; Tea Tot
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.